Dr. Das is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Lakeside Drive
Foster City, CA 94404Phone+1 650-522-4511- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Infectious Disease, 2005 - 2008
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
- CA State Medical License 2005 - 2025
Clinical Trials
- Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults Start of enrollment: 2014 Feb 25
Publications & Presentations
PubMed
- HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Anal...Raphael J Landovitz, Li Tao, Juan Yang, Melanie de Boer, Christoph Carter, Moupali Das, Jared M Baeten, Albert Liu, Karen W Hoover, Connie Celum, Beatriz Grinsztejn, S...> ;Clinical Infectious Diseases. 2024 Mar 14
- 1 citationsHIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.Jeanne Marrazzo, Li Tao, Marissa Becker, Ashley A Leech, Allan W Taylor, Faith Ussery, Michael Kiragu, Sushena Reza-Paul, Janet Myers, Linda-Gail Bekker, Juan Yang, Ch...> ;JAMA. 2024 Mar 19
- 4 citationsGender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.Yager, J., Prins, M., Krznaric, I., de Jong, J., Xiao, D., Shao, Y., Wong, P., Kintu, A., Carter, C., Hoornenborg, E., Ruane, P., Phoenix, J., Younis, I., Halperin, J....> ;Transgender Health. 2024 Feb 1
- Join now to see all
Journal Articles
- The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized HIV-Infected Patients in 11 U.S. CitiesDeborah K McMahon, Moupali Das, Wendy S Armstrong, Gregory M Lucas, Ank Nijhawan, Raul Mandler, Clinical Infectious Diseases
Press Mentions
- Dr. Moupali Das, MD, MPH — Gilead Sciences — Dedicated to Ending the HIV EpidemicMarch 7th, 2023
- HIV Capsid Inhibitor Offers New Option for People with Highly Resistant HIVMarch 10th, 2021
- Weight Gain While on ART: Demographic, HIV and Treatment-Related FactorsOctober 29th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: